Redmile Group, LLC — Form 4 insider transactions
Redmile Group, LLC — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Buy | Attovia Therapeutics, Inc. | 400,000 | $17.00 | $6,800,000 | SEC filing |
| 2026-08-06 | Buy | Attovia Therapeutics, Inc. | 200,000 | $17.00 | $3,400,000 | SEC filing |
| 2026-08-06 | Conversion | Attovia Therapeutics, Inc. | 782,854 | — | — | SEC filing |
| 2026-07-22 | Tax payment | Atara Biotherapeutics, Inc. | 60 | — | — | SEC filing |
| 2026-07-22 | Opt exercise | Atara Biotherapeutics, Inc. | 195,211 | — | — | SEC filing |
| 2026-04-20 | J | FATE THERAPEUTICS INC | 8,977,624 | — | — | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.